The affected person was handled with Velcade/Revlimid/dex as induction therapy and Yet another genetic check was done exhibiting the 1q attain at 70% of cells. The client relapsed in 18 months and had a hundred% of cells Along with the 1q gain, suggesting that testing for genetic features at diagnosis and all over again at relapse was crucial.  R